Stock listing

NRIX Stock Price, News, Filings & Events — Nurix Therapeutics, Inc.

Selected listing: NRIX · NASDAQ · USD · US

This page tracks Nurix Therapeutics, Inc.'s NRIX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NRIX:NASDAQ. NRIX:NASDAQ is the stock-level entry point for investors researching Nurix Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nurix Therapeutics, Inc. (ticker: NRIX) is a public company based in the United States, focused on developing innovative therapies for cancer and other diseases. With a market capitalization of approximately $2.4 billion, Nurix is engaged in advancing its proprietary drug discovery platform. The company aims to create targeted treatments that harness the body's natural processes to combat diseases effectively.